HIV-1-specific immune responses in subjects who temporarily contain virus replication after discontinuation of highly active antiretroviral therapy.
Ortiz GM, Nixon DF, Trkola A, Binley J, Jin X, Bonhoeffer S, Kuebler PJ, Donahoe SM, Demoitie MA, Kakimoto WM, Ketas T, Clas B, Heymann JJ, Zhang L, Cao Y, Hurley A, Moore JP, Ho DD, Markowitz M.
Ortiz GM, et al.
J Clin Invest. 1999 Sep;104(6):R13-8. doi: 10.1172/JCI7371.
J Clin Invest. 1999.
PMID: 10491418
Free PMC article.